Pharmacokinetics of Liposomal Amphotericin B (AmBisome) Given Intravenously to Patients Undergoing Bariatric Surgery
Phase of Trial: Phase IV
Latest Information Update: 16 Apr 2018
At a glance
- Drugs Amphotericin B liposomal (Primary)
- Indications Obesity
- Focus Pharmacokinetics
- Acronyms ASPEN
- 11 Apr 2018 Status changed from not yet recruiting to recruiting.
- 14 Nov 2017 Planned initiation date changed from 1 Oct 2017 to 1 Dec 2017.
- 02 Aug 2017 Planned initiation date changed from 1 Jun 2017 to 1 Oct 2017.